LENZ logo

LENZ Therapeutics, Inc. (LENZ) Cash and Cash Equivalents

Annual Cash & Cash Equivalents:

$209.14M+$143.35M(+217.88%)
December 31, 2024

Summary

  • As of today, LENZ annual cash & cash equivalents is $209.14 million, with the most recent change of +$143.35 million (+217.88%) on December 31, 2024.
  • During the last 3 years, LENZ annual cash & cash equivalents has fallen by -$167.83 million (-44.52%).
  • LENZ annual cash & cash equivalents is now -44.52% below its all-time high of $376.98 million, reached on December 1, 2021.

Performance

LENZ Cash and Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZbalance sheet metrics

Quarterly Cash & Cash Equivalents:

$202.17M-$7.46M(-3.56%)
September 30, 2025

Summary

  • As of today, LENZ quarterly cash & cash equivalents is $202.17 million, with the most recent change of -$7.46 million (-3.56%) on September 30, 2025.
  • Over the past year, LENZ quarterly cash & cash equivalents has dropped by -$15.05 million (-6.93%).
  • LENZ quarterly cash & cash equivalents is now -48.81% below its all-time high of $394.95 million, reached on September 1, 2021.

Performance

LENZ Quarterly Cash & Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZbalance sheet metrics

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

LENZ Cash and Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+217.9%-6.9%
3Y3 Years-44.5%-30.7%
5Y5 Years+10000.0%-

LENZ Cash and Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-44.5%+217.9%-30.7%+207.3%
5Y5-Year-44.5%>+9999.0%-48.8%+920.2%
All-TimeAll-Time-44.5%>+9999.0%-48.8%+920.2%

LENZ Cash and Cash Equivalents History

DateAnnualQuarterly
Sep 2025
-
$202.17M(-3.6%)
Jun 2025
-
$209.63M(+8.0%)
Mar 2025
-
$194.09M(-7.2%)
Dec 2024
$209.14M(+217.9%)
$209.14M(-3.7%)
Sep 2024
-
$217.22M(+10.7%)
Jun 2024
-
$196.23M(-8.0%)
Mar 2024
-
$213.39M(+224.3%)
Dec 2023
$65.79M(-75.5%)
$65.79M(-71.9%)
Sep 2023
-
$233.99M(-5.1%)
Jun 2023
-
$246.66M(-6.6%)
Mar 2023
-
$264.10M
DateAnnualQuarterly
Dec 2022
$268.23M(-28.8%)
-
Dec 2022
-
$268.23M(-8.0%)
Sep 2022
-
$291.69M(-9.5%)
Jun 2022
-
$322.29M(-5.0%)
Mar 2022
-
$339.18M(-10.0%)
Dec 2021
$376.98M(+1802.3%)
$376.98M(-4.6%)
Sep 2021
-
$394.95M(+3.4%)
Jun 2021
-
$382.11M(+115.7%)
Mar 2021
-
$177.16M(+794.0%)
Dec 2020
$19.82M(>+9900.0%)
$19.82M
Dec 2019
$6000.00
-

FAQ

  • What is LENZ Therapeutics, Inc. annual cash & cash equivalents?
  • What is the all-time high annual cash & cash equivalents for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
  • What is LENZ Therapeutics, Inc. quarterly cash & cash equivalents?
  • What is the all-time high quarterly cash & cash equivalents for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?

What is LENZ Therapeutics, Inc. annual cash & cash equivalents?

The current annual cash & cash equivalents of LENZ is $209.14M

What is the all-time high annual cash & cash equivalents for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high annual cash & cash equivalents is $376.98M

What is LENZ Therapeutics, Inc. annual cash & cash equivalents year-on-year change?

Over the past year, LENZ annual cash & cash equivalents has changed by +$143.35M (+217.88%)

What is LENZ Therapeutics, Inc. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of LENZ is $202.17M

What is the all-time high quarterly cash & cash equivalents for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $394.95M

What is LENZ Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?

Over the past year, LENZ quarterly cash & cash equivalents has changed by -$15.05M (-6.93%)
On this page